Algorae employs artificial intelligence to create new combinations of drugs for cancer treatment - The Sydney Morning Herald

Over 50% of American adults may qualify for Ozempic, study suggests - UPI.com

Novo Nordisk is offering a popular weight-loss drug in China for a significantly lower price compared to the United States, reports Ars Technica.

Positive Results: Eli Lilly's New Cholesterol Medication Shows Promise in Intermediate Study - NBC New York

Invest in this Pharmaceutical Company for Potential Profit from a Promising Weight-Loss Medication - News Source